OCSTAMP

gene
On this page

Also known as dJ257E24.3

Summary

OCSTAMP (osteoclast stimulatory transmembrane protein, HGNC:16116) is a protein-coding gene on chromosome 20q13.12, encoding Osteoclast stimulatory transmembrane protein (Q9BR26). Probable cell surface receptor that plays a role in cellular fusion and cell differentiation.

The protein encoded by this gene is orthologous to the mouse osteoclast stimulatory transmembrane protein (OCSTAMP), which is a membrane-anchored cell surface receptor that promotes nucleation of osteoclasts. The mouse protein is also involved in bone resorption and osteoclast differentiation.

Source: NCBI Gene 128506 — RefSeq curated summary.

At a glance

  • GWAS associations: 4
  • Clinical variants (ClinVar): 86 total
  • MANE Select transcript: NM_080721

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:16116
Approved symbolOCSTAMP
Nameosteoclast stimulatory transmembrane protein
Location20q13.12
Locus typegene with protein product
StatusApproved
AliasesdJ257E24.3
Ensembl geneENSG00000149635
Ensembl biotypeprotein_coding
OMIM620432
Entrez128506

Gene structure

Transcript identifiers

Ensembl transcripts: 1 — 1 protein_coding

ENST00000279028

RefSeq mRNA: 1 — MANE Select: NM_080721 NM_080721

CCDS: CCDS54468

Canonical transcript exons

ENST00000279028 — 3 exons

ExonStartEnd
ENSE000009917154654532746546329
ENSE000009917164654094646541927
ENSE000017031844655051746550654

Expression profiles

Bgee: expression breadth tissue_specific, 6 present calls, max score 44.35.

FANTOM5 (CAGE): breadth tissue_specific, TPM avg 1.4920 / max 172.1297, expressed in 111 samples.

FANTOM5 promoters (1 alternative TSS)

Promoter IDTPM avgSamples expressed
1875711.4920111

Top tissues by expression

117 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
bone marrow cellCL:000209244.35gold quality
sural nerveUBERON:001548837.66gold quality
colonic epitheliumUBERON:000039737.20gold quality
bone marrowUBERON:000237137.06gold quality
duodenumUBERON:000211437.00gold quality
ventricular zoneUBERON:000305336.48gold quality
cortical plateUBERON:000534336.47gold quality
superior frontal gyrusUBERON:000266135.29gold quality
lymph nodeUBERON:000002933.85gold quality
skeletal muscle tissueUBERON:000113433.38gold quality
adult mammalian kidneyUBERON:000008232.56silver quality
muscle tissueUBERON:000238532.37gold quality
hindlimb stylopod muscleUBERON:000425232.15gold quality
kidneyUBERON:000211332.03silver quality
mucosa of stomachUBERON:000119932.01gold quality
liverUBERON:000210730.44gold quality
adrenal tissueUBERON:001830330.09gold quality
stromal cell of endometriumCL:000225529.87gold quality
vermiform appendixUBERON:000115429.26gold quality
substantia nigraUBERON:000203829.15silver quality
islet of LangerhansUBERON:000000629.07gold quality
monocyteCL:000057628.57gold quality
leukocyteCL:000073828.48gold quality
smooth muscle tissueUBERON:000113528.38silver quality
metanephros cortexUBERON:001053327.93gold quality
Ammon’s hornUBERON:000195427.90gold quality
placentaUBERON:000198727.54gold quality
primary visual cortexUBERON:000243627.39gold quality
bloodUBERON:000017826.88gold quality
Brodmann (1909) area 9UBERON:001354026.87gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 0.

ExperimentMarker?Max mean expression
E-ANND-3no1.47

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

14 targeting OCSTAMP, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-3163100.0077.238605
HSA-MIR-433-3P99.9869.371203
HSA-MIR-182799.6368.573265
HSA-MIR-1252-3P99.5567.712862
HSA-MIR-766-5P99.4767.912225
HSA-MIR-1304-5P98.9068.581054
HSA-MIR-5011-3P98.6364.81638
HSA-MIR-66597.6065.641781
HSA-MIR-625-3P97.3266.55554
HSA-MIR-227897.3066.191130
HSA-MIR-3121-5P97.3066.621146
HSA-MIR-608296.4070.86216
HSA-MIR-877-5P94.6266.30710
HSA-MIR-4732-5P90.0764.77412

Literature-anchored findings (GeneRIF, showing 2)

  • Results indicte that oc-stamp may play an important role in macrophage polarization and inhibit the M1 pro-inflammatory state. (PMID:28981605)
  • Osteoclast stimulatory transmembrane protein (OC-STAMP) is a promising molecular prognostic indicator for multiple myeloma. (PMID:32282962)

Cross-species orthologs

3 orthologs

OrganismSymbolGene ID
danio_rerioocstampENSDARG00000022139
mus_musculusOcstampENSMUSG00000027670
rattus_norvegicusOcstampENSRNOG00000019110

Paralogs (3): DCST2 (ENSG00000163354), DCST1 (ENSG00000163357), DCSTAMP (ENSG00000164935)

Protein

Protein identifiers

Osteoclast stimulatory transmembrane proteinQ9BR26 (reviewed: Q9BR26)

All UniProt accessions (1): Q9BR26

UniProt curated annotations — full annotation on UniProt →

Function. Probable cell surface receptor that plays a role in cellular fusion and cell differentiation. Cooperates with DCSTAMP in modulating cell-cell fusion in both osteoclasts and foreign body giant cells (FBGCs). Involved in osteoclast bone resorption. Promotes osteoclast differentiation and may play a role in the multinucleated osteoclast maturation.

Subcellular location. Membrane.

RefSeq proteins (1): NP_542452* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR012858DC_STAMP-likeDomain
IPR051856CSR-E3_Ligase_ProteinFamily

Pfam: PF07782

UniProt features (15 total): topological domain 7, transmembrane region 6, chain 1, sequence variant 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q9BR26-F174.400.34

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 88 (showing top): GOBP_MYELOID_CELL_DIFFERENTIATION, GOBP_REGULATION_OF_LEUKOCYTE_PROLIFERATION, GOBP_REGULATION_OF_OSTEOCLAST_DIFFERENTIATION, GOBP_POSITIVE_REGULATION_OF_HEMOPOIESIS, GOBP_RESPONSE_TO_PEPTIDE, GOBP_MYELOID_LEUKOCYTE_DIFFERENTIATION, GOBP_POSITIVE_REGULATION_OF_LEUKOCYTE_PROLIFERATION, GOBP_REGULATION_OF_LEUKOCYTE_DIFFERENTIATION, GOBP_REGULATION_OF_HEMOPOIESIS, GOBP_LEUKOCYTE_PROLIFERATION, GOBP_CELLULAR_RESPONSE_TO_HORMONE_STIMULUS, SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM3, GOBP_POSITIVE_REGULATION_OF_CELL_DIFFERENTIATION, GOBP_POSITIVE_REGULATION_OF_OSTEOCLAST_DIFFERENTIATION, GOBP_REGULATION_OF_SYNCYTIUM_FORMATION_BY_PLASMA_MEMBRANE_FUSION

GO Biological Process (7): positive regulation of macrophage fusion (GO:0034241), positive regulation of osteoclast differentiation (GO:0045672), cellular response to tumor necrosis factor (GO:0071356), cellular response to estrogen stimulus (GO:0071391), multinuclear osteoclast differentiation (GO:0072674), positive regulation of osteoclast proliferation (GO:0090290), cell differentiation (GO:0030154)

GO Molecular Function (0):

GO Cellular Component (1): membrane (GO:0016020)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
osteoclast differentiation2
macrophage fusion1
regulation of macrophage fusion1
positive regulation of syncytium formation by plasma membrane fusion1
positive regulation of myeloid leukocyte differentiation1
regulation of osteoclast differentiation1
response to tumor necrosis factor1
cellular response to cytokine stimulus1
cellular response to hormone stimulus1
response to estrogen1
osteoclast proliferation1
positive regulation of leukocyte proliferation1
regulation of osteoclast proliferation1
cellular developmental process1
cellular anatomical structure1

Protein interactions and networks

STRING

286 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
OCSTAMPDCSTAMPQ9H295930
OCSTAMPATP6V0D2Q8N8Y2774
OCSTAMPNFATC1O95644750
OCSTAMPCTSKP43235738
OCSTAMPACP5P13686699
OCSTAMPTNFSF11O14788673
OCSTAMPOSCARQ8IYS5649
OCSTAMPMMP9P14780615
OCSTAMPCALCRP30988536
OCSTAMPDCST1Q5T197485
OCSTAMPFOSP01100478
OCSTAMPTRAF6Q9Y4K3452
OCSTAMPCLCN7P51798444
OCSTAMPITGB3P05106427
OCSTAMPCSF1P09603408

IntAct

0 interactions, top by confidence:

ESM2 similar proteins: A0JN53, A0PJX8, A1L1L2, A1L3T7, A4FV45, B0BMG8, E2JF22, G3HQ82, O15360, O43299, O70491, P60330, Q0KL00, Q0V8E7, Q17Q97, Q24JP3, Q3U829, Q49LS3, Q4QR83, Q562E7, Q5ND34, Q5R7B4, Q5T1A1, Q5XG04, Q6NUQ4, Q6PH58, Q6UX68, Q7L4E1, Q7Z412, Q8BGI5, Q8BM55, Q8BSD4, Q8BXV2, Q8C3R1, Q8C7B8, Q8IXR5, Q8K0R6, Q8N6S5, Q8R115, Q8VCA6

Diamond homologs: Q9BR26, Q9D611

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

86 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance77
Likely benign8
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

444 predictions. Top by Δscore:

VariantEffectΔscore
20:46541924:CCAC:Cacceptor_gain1.0000
20:46541925:CAC:Cacceptor_gain1.0000
20:46541925:CACC:Cacceptor_gain1.0000
20:46541927:CCT:Cacceptor_gain1.0000
20:46541927:CCTT:Cacceptor_loss1.0000
20:46541928:CTTGG:Cacceptor_loss1.0000
20:46541929:T:Aacceptor_loss1.0000
20:46541929:T:Cacceptor_gain1.0000
20:46541929:T:TCacceptor_gain1.0000
20:46541923:GCCAC:Gacceptor_gain0.9900
20:46541924:CCACC:Cacceptor_gain0.9900
20:46541928:C:CCacceptor_gain0.9900
20:46545335:TG:Tdonor_gain0.9900
20:46545325:A:ACdonor_gain0.9800
20:46545326:C:CCdonor_gain0.9800
20:46545326:CAT:Cdonor_gain0.9800
20:46541928:C:Tacceptor_gain0.9700
20:46549303:T:Cdonor_gain0.9700
20:46541926:AC:Aacceptor_gain0.9600
20:46545320:CACT:Cdonor_loss0.9500
20:46545321:ACTTA:Adonor_loss0.9500
20:46545322:CTTAC:Cdonor_loss0.9500
20:46545323:TTA:Tdonor_loss0.9500
20:46545324:TACAT:Tdonor_loss0.9500
20:46545325:A:Tdonor_loss0.9500
20:46545326:C:CAdonor_loss0.9500
20:46542663:ATGT:Adonor_gain0.9400
20:46545332:A:ACdonor_gain0.9400
20:46545333:C:CCdonor_gain0.9400
20:46549302:A:ACdonor_gain0.9400

AlphaMissense

3580 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
20:46545612:A:CF254L0.975
20:46545612:A:TF254L0.975
20:46545614:A:GF254L0.975
20:46545402:G:CF324L0.970
20:46545402:G:TF324L0.970
20:46545404:A:GF324L0.970
20:46541676:G:CF433L0.956
20:46541676:G:TF433L0.956
20:46541678:A:GF433L0.956
20:46541673:G:CF434L0.953
20:46541673:G:TF434L0.953
20:46541675:A:GF434L0.953
20:46545996:G:CS126R0.951
20:46545996:G:TS126R0.951
20:46545998:T:GS126R0.951
20:46541835:C:AW380C0.943
20:46541835:C:GW380C0.943
20:46545951:G:CN141K0.942
20:46545951:G:TN141K0.942
20:46545606:A:CN256K0.938
20:46545606:A:TN256K0.938
20:46546047:G:CS109R0.937
20:46546047:G:TS109R0.937
20:46546049:T:GS109R0.937
20:46545923:A:GC151R0.922
20:46541904:G:CF357L0.917
20:46541904:G:TF357L0.917
20:46541906:A:GF357L0.917
20:46545897:A:CS159R0.913
20:46545897:A:TS159R0.913

dbSNP variants (sampled 300 via entrez): RS1000137103 (20:46552544 C>G), RS1000173141 (20:46550749 C>T), RS1000203180 (20:46549582 A>T), RS1000356828 (20:46546773 C>A,G), RS1000693130 (20:46545652 G>A,C,T), RS1001219080 (20:46543795 A>G,T), RS1001507774 (20:46547706 A>G), RS1001594246 (20:46544169 T>G), RS1001755140 (20:46549639 A>C), RS1001843150 (20:46546121 CA>C), RS1001954565 (20:46552429 T>C), RS1002104783 (20:46546381 T>A,C,G), RS1002145182 (20:46549967 T>G), RS1002730156 (20:46541554 G>A), RS1003212695 (20:46545554 G>A,T)

Disease associations

OMIM: gene MIM:620432 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

4 associations (top):

StudyTraitp-value
GCST005956_29Waist-to-hip ratio adjusted for BMI4.000000e-10
GCST005957_10Waist-to-hip ratio adjusted for BMI (age <50)5.000000e-06
GCST005958_17Waist-to-hip ratio adjusted for BMI (age >50)3.000000e-06
GCST005962_25Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test)1.000000e-09

EFO canonical traits (3, from GWAS)

EFO IDTrait name
EFO:0007788BMI-adjusted waist-hip ratio
EFO:0008007age at assessment
EFO:0008343sex interaction measurement

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

7 total (human), top 7 by PubMed support.

ChemicalActions (top 5)PubMed papers
aflatoxin B2increases methylation1
Resveratrolaffects cotreatment, decreases expression1
Leflunomideincreases expression1
Benzo(a)pyreneaffects methylation1
Cholesterolincreases expression1
Malathionincreases expression1
Plant Extractsaffects cotreatment, decreases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.